Filter by: Reset All
- Showing 14776 - 14790 of 19776 results (Page 986)
- Sort by
-
The Intracranial Pressure Monitoring Device market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Intracranial Pressure Monitoring Device is projected to grow from US$ xx million in...$0Read More
-
The Rosuvastatin market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Rosuvastatin is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR...$0Read More
-
The Cholangiopancreatography Device market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Cholangiopancreatography Device is projected to grow from US$ xx million in 2020, and is projected...$3,360Read More
-
The Primary Sclerosing Cholangitis Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Primary Sclerosing Cholangitis Treatment is projected to grow from US$ xx million...$0Read More
-
The Output Neural Prosthetics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Output Neural Prosthetics is projected to grow from US$ xx million in 2020, and is projected to reach...$0Read More
-
The Morphogenetic Protein market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Morphogenetic Protein is projected to grow from US$ xx million in 2020, and is projected to reach xx...$3,360Read More
-
The Traumatic Brain Injury Therapeutics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Traumatic Brain Injury Therapeutics is projected to grow from US$ xx million in 2020, and...$0Read More
-
The 5 Nucleotidase market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for 5 Nucleotidase is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a...$3,360Read More
-
The Multiple Sclerosis (MS) Drugs market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Multiple Sclerosis (MS) Drugs is projected to grow from US$ xx million in 2020, and is projected...$0Read More
-
The Digital Electronic Colposcope market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Digital Electronic Colposcope is projected to grow from US$ xx million in 2020, and is projected...$0Read More
-
The Manual External Defibrillator market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Manual External Defibrillator is projected to grow from US$ xx million in 2020, and is projected...$0Read More
-
The Medicine Iontophoresis Instrument market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Medicine Iontophoresis Instrument is projected to grow from US$ xx million in 2020, and is...$0Read More
-
The Dental Biomaterials market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Dental Biomaterials is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025,...$3,360Read More
-
The Genitourinary System Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Genitourinary System Treatment is projected to grow from US$ xx million in 2020, and is projected...$0Read More
-
The Anastrozole (CAS 120511-73-1) market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Anastrozole (CAS 120511-73-1) is projected to grow from US$ xx million in 2020, and is projected...$0Read More
Our Clients